Emerald Health Therapeutics Confirms Supply Agreement with Ontario Cannabis Retail Corporation to Supply Adult-Use Cannabis P...
September 07 2018 - 7:00AM
Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF)
(“Emerald”) today announced that it has been selected as an
approved supplier by the Ontario Cannabis Retail Corporation,
operating as the Cannabis Retail Store (“OCS”), to supply the
province of Ontario with its cannabis products in anticipation of
the adult-use market starting October 17, 2018. Quantities will be
disclosed once details have been released by the Province of
Ontario.
“We’re proud to partner with the OCS to provide
adults in Ontario with the opportunity to discover our products,”
said Chris Wagner, CEO at Emerald. “We look forward to helping
Ontario expand its supply and diversity of products to meet
anticipated demand and consumer preferences. With more than 14
million people, Ontario is a key market for us as we expand
nationwide and build our brand.”
Emerald is focused on product innovation that
will command high profit margins; differentiating marketing,
distribution, and sales strategies; and securing significant
supplies of safe, quality, and low-cost cannabis.
About Emerald Health Therapeutics,
Inc.
Emerald Health Therapeutics (TSXV: EMH; OTCQX:
EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access
to Cannabis for Medical Purposes Regulations and produces and sells
dried cannabis and cannabis oil for medical purposes. Emerald owns
50% of Pure Sunfarms, which is converting a licensed existing 1.1
million square foot greenhouse in Delta, BC, and is now in
commercial production. It owns Agro-Biotech, a Quebec-based
licensed cannabis grower with a 75,000 square foot indoor facility,
and is planning to add a 500,000 square foot greenhouse in Metro
Vancouver. Emerald’s team is highly experienced in life sciences,
product development, large-scale agribusiness, and marketing, and
is focused on developing value-added cannabis-based products with
potential wellness and medical benefits. Emerald is part of the
Emerald Health group, which is broadly focused on developing
pharmaceutical, botanical and nutraceutical products that may
provide wellness and medical benefits by interacting with the human
body’s endocannabinoid system.
Please visit www.emeraldhealth.ca for more
information or contact:Rob Hill, Chief Financial Officer(800) 757
3536 Ext. #5
Ray Lagace, Investor Relations Manager(800) 757
3536 Ext. #5invest@emeraldhealth.ca
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking
Statements: Certain statements made in this press release that are
not historical facts are forward-looking statements and are subject
to important risks, uncertainties and assumptions, both general and
specific, which give rise to the possibility that actual results or
events could differ materially from our expectations expressed in
or implied by such forward-looking statements. Such statements
include legalization of nonmedicinal cannabis; production capacity
of various facilities; expansion of facilities; and anticipated
production costs.
We cannot guarantee that any forward-looking
statement will materialize, and readers are cautioned not to place
undue reliance on these forward-looking statements. These
forward-looking statements involve risks and uncertainties related
to, among other things, failure to obtain regulatory approvals;
failure to obtain necessary financing; results of production and
sale activities; results of scientific research; regulatory
changes; changes in prices and costs of inputs; demand for labour;
demand for products; as well as the risk factors described in the
Company’s annual information form and other regulatory filings. The
forward-looking statements contained in this press release
represent our expectations as of the date hereof. Forward-looking
statements are presented for the purpose of providing information
about management's current expectations and plans and allowing
investors and others to obtain a better understanding of our
anticipated operating environment. Readers are cautioned that such
information may not be appropriate for other purposes. The Company
undertakes no obligations to update or revise such statements to
reflect new circumstances or unanticipated events as they occur,
unless required by applicable law.
Emerald Health Therapeut... (TSXV:EMH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emerald Health Therapeut... (TSXV:EMH)
Historical Stock Chart
From Apr 2023 to Apr 2024